Non-Invasive Diagnostics to Improve Gynecologic Health (R43/R44 – Clinical Trial Optional)

Funder: National Institutes of Health

Due Date: 3/30/2018

Budget: Negotiable

Opportunity: RFA-HD-19-006

The purpose of this FOA is to encourage small businesses to collaborate with scientists and clinicians in the field of gynecologic health to develop, advance, and validate new devices and methods for non-invasive diagnosis of endometriosis, adenomyosis, and/or uterine fibroids. Projects supported will aim to shorten the time to diagnosis, decrease the invasiveness of current techniques, and/or improve accessibility, safety, convenience, and costs of diagnosis.

Leave a Reply